A possible therapy would be the adoptive transfer of NK cells expressing receptors for these ligands (i.e. NKp30, CD2, or NKG2D) to induce the elimination of residual tumor cells, prevent relapse and improve patient survival. Here, KLRK1 is linked to neoplasm.